Latest News & Features
Americas
Law firm Goodwin Procter has promoted five lawyers to partner in the firm’s intellectual property practice, including two life sciences specialists. 5 October 2015
Americas
The US Federal Trade Commission has intervened in a ‘product hopping’ dispute concerning an acne treatment drug. 2 October 2015
Big Pharma
Representatives from the pharmaceutical and engineering industries have said that the decision to opt existing patents into the Unified Patent Court will be a strategic decision done on a case-by-case basis. 2 October 2015
Big Pharma
The UK health secretary has been urged by a health campaigning group to issue a compulsory licence for a breast cancer patent owned by Swiss pharmaceutical company Roche. 1 October 2015
Americas
A US presidential hopeful for the Democratic Party has urged the US to support a request that would permanently free poor countries from their responsibility to grant patent protection for drugs. 30 September 2015
Americas
Pharmaceutical company Allergan has survived an attempt by hedge fund Ferrum Ferro Capital to invalidate a patent covering its Combigan drug after the Patent Trial and Appeal Board opted not to institute an inter partes review. 29 September 2015
Asia-Pacific
A Japanese lawyer has described a ruling by the Supreme Court of Japan as a “death sentence” for product-by-process patents and said it is a good time for drugs companies to challenge rivals’ patents. 29 September 2015
Americas
Biopharmaceutical company Celgene has reiterated its stance on the inter partes review petitions filed by hedge fund manager Kyle Bass and has hinted it will appeal against a recent unfavourable decision. 29 September 2015
Americas
The US Patent and Trademark Office has rejected a request by biopharmaceutical company Celgene to sanction hedge fund manager Kyle Bass and his organisation the Coalition for Affordable Drugs. 28 September 2015
Americas
Concern surrounding how the Unified Patent Court will operate echoes the worry that US patent owners had ahead of the Patent Trial and Appeal Board’s implementation, a US law firm has observed. 28 September 2015